Neurological Diseases or Conditions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurological Diseases or Conditions trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurological Diseases or Conditions trials you may qualify forThis study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMA…
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of ag…
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and ad…
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN1…
The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia…
This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine…
This study aims to examine the knowledge levels and attitudes of students enrolled in departments other than Audiology within the Faculty of Health Sciences reg…
The aim of this methodological study is to adapt the Fugl-Meyer assessment to Turkish culture and to test its validity and reliability in acute phase stroke pat…
The goal of this observational study is to gather additional safety and performance (effectiveness) data on the device for the treatment of symptomatic lower ex…